Cytomegalovirus latency-the sum of subtleties
Meaghan H Hancock1, Patrizia Caposio1, Donna Collins-McMillen2
1Vaccine and Gene Therapy Institute, Oregon Health and Science Institute, Beaverton, Oregon, USA.
Abstract:
Human cytomegalovirus (HCMV) is a betaherpesvirus, which, like all herpesviruses, establishes a life-long latent infection while retaining the ability to reactivate its replicative program. While HCMV likely reactivates frequently and sporadically in healthy individuals and typically without disease, reactivation poses a serious disease threat in the immunocompromised. The latent program of HCMV is complex and has been challenging to define due to limitations in appropriate experimental model systems related to virus-host species specificity, limited identification of in vivo latent reservoirs, and the dynamic cellular differentiation of the hematopoietic latency reservoir that is directly linked to latency maintenance and reactivation phenotypes. Here, we review the current understanding of HCMV latency, with a focus on cross-cutting principles derived collectively from in vitro experimental culture models and in vivo animal models using the corresponding orthologs (CMVs) to HCMV.
Related Concept Videos
Retrovirus Life Cycles
Size and Structure of Viral Genomes
Viruses with RNA Genomes
Retroviruses
Immunological Memory
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...


